Evidence map›Paper›PMID 40002890›Full record

ArticleBiomedicines2025

Prognostic Value of Tumor Dissemination (Dmax) Derived from Basal 18F-FDG Positron Emission Tomography/Computed Tomography in Patients with Advanced Non-Small-Cell Lung Cancer.

Sara Pellegrino, Rosa Fonti, Rocco Morra, Erica Di Donna, Alberto Servetto, Roberto Bianco, Silvana Del Vecchio

Abstract read
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Diagnostic performance ofEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Brain Metabolic Activity Measured by [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sara PellegrinoDepartment of Advanced Biomedical Sciences, University of Naples "Federico II", 80131 Naples, Italy.
Rosa FontiDepartment of Advanced Biomedical Sciences, University of Naples "Federico II", 80131 Naples, Italy.
Rocco MorraDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", 80131 Naples, Italy.ORCID 0000-0002-2516-076X
Erica Di DonnaDepartment of Advanced Biomedical Sciences, University of Naples "Federico II", 80131 Naples, Italy.
Alberto ServettoDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", 80131 Naples, Italy.ORCID 0000-0003-3624-224X
Roberto BiancoDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", 80131 Naples, Italy.
Silvana Del VecchioDepartment of Advanced Biomedical Sciences, University of Naples "Federico II", 80131 Naples, Italy.ORCID 0000-0002-5466-1213

Funding

European Union Next Generation EU - Health Minister Italy PNRR-MCNT2-2023-12377713, CUP C63C24000370006
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

18F-FDG PET/CTnon-small-cell lung cancerprognosistumor dissemination Dmax

Identifiers

PMID40002890
PMCPMC11853205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.